Life Technologies reported $3.48M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Applied Genetic Technologies AGTC:US $ 4.32M 494K
Biogen BIIB:US $ 572.6M 62.3M
Bristol Myers Squibb BMY:US $ 1.78B 46M
Chimerix CMRX:US 5.84M 208K
Curis CRIS:US $ 5.09M 584K
Galapagos GLPG:NA 71.67M 9.33M
GlaxoSmithKline GSK:LN 1.96B 726M
Life Technologies LIFE:US $ 3.48M 797K
Nanostring Technologies NSTG:US $ 36.11M 243K
Novartis NOVN:VX 3.59B 91M
United Therapeutics UTHR:US $ 141.5M 62.5M
Xoma XOMA:US $ 5.71M 594K